Fallopian tube secretory cell expansion: A sensitive biomarker for ovarian serous carcinogenesis

American Journal of Translational Research

Volumn 7, Issue 10, 2015, Pages 2082-2090

  Wang, Yiying ^a,b   Li, Li ^b,c   Wang, Yue ^a   Tang, Sarah Ngocvi ^d   Zheng, Wenxin ^b,c,d,e  

^a HENAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^b UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^c SHANDONG UNIVERSITY   (China)

^d UNIVERSITY OF ARIZONA COLLEGE OF MEDICINE   (United States)

^e UNIVERSITY OF TEXAS AT DALLAS   (United States)

Author keywords

Carcinogenesis; Fallopian tube; Ovarian cancer; Pathogenesis; Pelvic serous carcinoma; Tubal secretory cells

Indexed keywords

KI 67 ANTIGEN; PROTEIN P53;

ADULT; AGED; ARTICLE; BLOOD CELL RATIO; CARCINOGENESIS; CELL EXPANSION; CELL GROWTH; CLINICAL ARTICLE; FEMALE; GENE MUTATION; HISTOLOGY; HUMAN; HUMAN TISSUE; HYSTERECTOMY; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MIDDLE AGED; OVARY CANCER; RISK FACTOR; SALPINGECTOMY; UTERINE TUBE;

EID: 84947740063     PISSN: None     EISSN: 19438141     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Cannistra SA. Cancer of the ovary. N Engl J Med 1993; 329: 1550-1559.
2. Li J, Fadare O, Xiang L, Kong B and Zheng W. Ovarian serous carcinoma: recent concepts on its origin and carcinogenesis. J Hematol Oncol 2012; 5: 8.
3. Delair D and Soslow RA. Key features of extrauterine pelvic serous tumours (fallopian tube, ovary, and peritoneum). Histopathology 2012; 61: 329-339.
4. Brewer MA, Johnson K, Follen M, Gershenson D and Bast R Jr. Prevention of ovarian cancer: intraepithelial neoplasia. Clin Cancer Res 2003; 9: 20-30.
5. Li J, Abushahin N, Pang S, Xiang L, Chambers SK, Fadare O, Kong B and Zheng W. Tubal origin of ‘ovarian’ low-grade serous carcinoma. Mod Pathol 2011; 24: 1488-1499.
6. Quick CM, Ning G, Bijron J, Laury A, Wei TS, Chen EY, Vargas SO, Betensky RA, McKeon FD, Xian W and Crum CP. PAX2-null secretory cell outgrowths in the oviduct and their relationship to pelvic serous cancer. Mod Pathol 2012; 25: 449-455.
7. Carlson JW, Miron A, Jarboe EA, Parast MM, Hirsch MS, Lee Y, Muto MG, Kindelberger D and Crum CP. Serous tubal intraepithelial carcinoma: its potential role in primary peritoneal serous carcinoma and serous cancer prevention. J Clin Oncol 2008; 26: 4160-4165.
8. Crum CP, Drapkin R, Miron A, Ince TA, Muto M, Kindelberger DW and Lee Y. The distal fallopian tube: a new model for pelvic serous carcinogenesis. Curr Opin Obstet Gynecol 2007; 19: 3-9.
9. Lee Y, Miron A, Drapkin R, Nucci MR, Medeiros F, Saleemuddin A, Garber J, Birch C, Mou H, Gordon RW, Cramer DW, McKeon FD and Crum CP. A candidate precursor to serous carcinoma that originates in the distal fallopian tube. J Pathol 2007; 211: 26-35.
10. Callahan MJ, Crum CP, Medeiros F, Kindelberger DW, Elvin JA, Garber JE, Feltmate CM, Berkowitz RS and Muto MG. Primary fallopian tube malignancies in BRCA-positive women undergoing surgery for ovarian cancer risk reduction. J Clin Oncol 2007; 25: 3985-3990.
11. Crum CP. Intercepting pelvic cancer in the distal fallopian tube: theories and realities. Mol Oncol 2009; 3: 165-170.
12. Zhang W, Wei L, Li L, Yang B, Kong B, Yao G and Zheng W. Ovarian serous carcinogenesis from tubal secretory cells. Histol Histopathol 2015; 30: 1295-302.
13. Chen EY, Mehra K, Mehrad M, Ning G, Miron A, Mutter GL, Monte N, Quade BJ, McKeon FD, Yassin Y, Xian W and Crum CP. Secretory cell outgrowth, PAX2 and serous carcinogenesis in the Fallopian tube. J Pathol 2010; 222: 110-116.
14. Levanon K, Ng V, Piao HY, Zhang Y, Chang MC, Roh MH, Kindelberger DW, Hirsch MS, Crum CP, Marto JA and Drapkin R. Primary ex vivo cultures of human fallopian tube epithelium as a model for serous ovarian carcinogenesis. Oncogene 2010; 29: 1103-1113.
15. Mehra K, Mehrad M, Ning G, Drapkin R, McKeon FD, Xian W and Crum CP. STICS, SCOUTs and p53 signatures; a new language for pelvic serous carcinogenesis. Front Biosci (Elite Ed) 2011; 3: 625-634.
16. Crum CP, McKeon FD and Xian W. BRCA, the oviduct, and the space and time continuum of pelvic serous carcinogenesis. Int J Gynecol Cancer 2012; 22 Suppl 1: S29-34.
17. Colgan TJ. Challenges in the early diagnosis and staging of Fallopian-tube carcinomas associated with BRCA mutations. Int J Gynecol Pathol 2003; 22: 109-120.
18. Shaw PA, Rouzbahman M, Pizer ES, Pintilie M and Begley H. Candidate serous cancer precursors in fallopian tube epithelium of BRCA-1/2 mutation carriers. Mod Pathol 2009; 22: 1133-1138.
19. Jarboe E, Folkins A, Nucci MR, Kindelberger D, Drapkin R, Miron A, Lee Y and Crum CP. Serous carcinogenesis in the fallopian tube: a descriptive classification. Int J Gynecol Pathol 2008; 27: 1-9.
20. Li J, Ning Y, Abushahin N, Yuan Z, Wang Y, Wang Y, Yuan B, Cragun JM, Chambers SK, Hatch K, Kong B and Zheng W. Secretory cell expansion with aging: risk for pelvic serous carcinogenesis. Gynecol Oncol 2013; 131: 555-560.
21. Piek JM, van Diest PJ, Zweemer RP, Jansen JW, Poort-Keesom RJ, Menko FH, Gille JJ, Jongsma AP, Pals G, Kenemans P and Verheijen RH. Dysplastic changes in prophylactically removed Fallopian tubes of women predisposed to developing ovarian cancer. J Pathol 2001; 195: 451-456.
22. Kindelberger DW, Lee Y, Miron A, Hirsch MS, Feltmate C, Medeiros F, Callahan MJ, Garner EO, Gordon RW, Birch C, Berkowitz RS, Muto MG and Crum CP. Intraepithelial carcinoma f the fimbria and pelvic serous carcinoma: Evidence for a causal relationship. Am J Surg Pathol 2007; 31: 161-169.
23. Medeiros F, Muto MG, Lee Y, Elvin JA, Callahan MJ, Feltmate C, Garber JE, Cramer DW and Crum CP. The tubal fimbria is a preferred site for early adenocarcinoma in women with familial ovarian cancer syndrome. Am J Surg Pathol 2006; 30: 230-236.
24. Lang D, Powell SK, Plummer RS, Young KP and Ruggeri BA. PAX genes: roles in development, pathophysiology, and cancer. Biochem Pharmacol 2007; 73: 1-14.
25. Bowen NJ, Logani S, Dickerson EB, Kapa LB, Akhtar M, Benigno BB and McDonald JF. Emerging roles for PAX8 in ovarian cancer and endosalpingeal development. Gynecol Oncol 2007; 104: 331-337.
26. Mittag J, Winterhager E, Bauer K and Grummer R. Congenital hypothyroid female pax8-deficient mice are infertile despite thyroid hormone replacement therapy. Endocrinology 2007; 148: 719-725.
27. Nonaka D, Chiriboga L and Soslow RA. Expression of pax8 as a useful marker in distinguishing ovarian carcinomas from mammary carcinomas. Am J Surg Pathol 2008; 32: 1566-1571.
28. Tong GX, Devaraj K, Hamele-Bena D, Yu WM, Turk A, Chen X, Wright JD and Greenebaum E. Pax8: a marker for carcinoma of Mullerian origin in serous effusions. Diagn Cytopathol 2011; 39: 567-574.
29. Laury AR, Hornick JL, Perets R, Krane JF, Corson J, Drapkin R and Hirsch MS. PAX8 reliably distinguishes ovarian serous tumors from malignant mesothelioma. Am J Surg Pathol 2010; 34: 627-635.
30. Goodman MT and Shvetsov YB. Incidence of ovarian, peritoneal, and fallopian tube carcinomas in the United States, 1995-2004. Cancer Epidemiol Biomarkers Prev 2009; 18: 132-139.
31. Crum CP, McKeon FD and Xian W. The oviduct and ovarian cancer: causality, clinical implications, and “targeted prevention”. Clin Obstet Gynecol 2012; 55: 24-35.
32. Folkins AK, Jarboe EA, Roh MH and Crum CP. Precursors to pelvic serous carcinoma and their clinical implications. Gynecol Oncol 2009; 113: 391-396.
33. Levanon K, Crum C and Drapkin R. New insights into the pathogenesis of serous ovarian cancer and its clinical impact. J Clin Oncol 2008; 26: 5284-5293.
34. Hunn J and Rodriguez GC. Ovarian cancer: etiology, risk factors, and epidemiology. Clin Obstet Gynecol 2012; 55: 3-23.
35. Semmel DR, Folkins AK, Hirsch MS, Nucci MR and Crum CP. Intercepting early pelvic serous carcinoma by routine pathological examination of the fimbria. Mod Pathol 2009; 22: 985-988.
36. Vang R, Shih Ie M and Kurman RJ. Fallopian tube precursors of ovarian low-and high-grade serous neoplasms. Histopathology 2013; 62: 44-58.
37. Tang S, Onuma K, Deb P, Wang E, Lytwyn A, Sur M and Daya D. Frequency of serous tubal intraepithelial carcinoma in various gynecologic malignancies: a study of 300 consecutive cases. Int J Gynecol Pathol 2012; 31: 103-110.
38. Wen J, Shi JL, Shen DH, Chen YX and Song QJ. [Morphologic changes of fallopian tubal epithelium in ovarian serous tumors]. Zhonghua Bing Li Xue Za Zhi 2012; 41: 433-437.